parallel group design crossover design group approach individual approach consequences heterogeneity response drugs clinical development programs new antihypertensive drugs care individual hypertensive patient role inappropriate choice too-high daily doses antihypertensive drugs end extensive international development programs insufficient control blood pressure long-term multicenter trials hypertension patients several years drugs appropriate disease blood pressure addition parallel group studies use double-blind two-period multiple period crossover designs valid data dose-finding new antihypertensive drugs comparative evaluation end trial designs patient opportunity right dose drug appropriate disease 